Goldman Sachs Downgrades Hermes International to Sell

Goldman Sachs downgrades Hermes International (OTC:HESAY) from Neutral to Sell.

byBenzinga Newsdesk

November 9, 2021

1 minute read

Goldman Sachs downgrades Hermes International (OTC:HESAY) from Neutral to Sell.

66 Biggest Movers From Friday

By Lisa Levin

November 1, 4:36 AM

Gainers Bakkt Holdings, Inc. (NASDAQ: BKKT) shares surged 66.1% to close at $42.52 on Friday on continued volatility after the company recently announced partnerships with Mastercard and Fiserv.

AAPL

The Daily Biotech Pulse: Lilly Spikes On Alzheimer’s Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO

By Shanthi Rexaline

June 24, 8:10 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23)

ABCL

Pfizer, Valneva Discontinue Certain Trial Sites For Phase 3 Study Of Lyme Disease Vaccine Candidate

By Vandana Singh

February 17, 6:47 AM

Pfizer Inc (NYSE:PFE) and Valneva SE (NASDAQ:VALN) announce that Pfizer, as the study sponsor, will discontinue a significant percentage of participants in the…

PFE

GameStop Partners With Crypto Exchange FTX: What You Need To Know

By Samyuktha Sriram

September 7, 6:20 PM

Major video game retailer GameStop Corp. (NYSE: GME) has partnered with cryptocurrency exchange FTX to bring more customers to the digital asset space.

$DOGE

Goldman Sachs Downgrades Hermes International to Sell

Related Posts

66 Biggest Movers From Friday

The Daily Biotech Pulse: Lilly Spikes On Alzheimer’s Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO

Pfizer, Valneva Discontinue Certain Trial Sites For Phase 3 Study Of Lyme Disease Vaccine Candidate

GameStop Partners With Crypto Exchange FTX: What You Need To Know